{"id":"44b7ff03-e961-5850-8e29-60bb8b5e6de8","stable_key":"9a47f338-d127-5e4d-abf6-e99056833a69:d-aspartate-human-low-dasp","predicate":"associates_with","statement":"Schizophrenia DLPFC samples had approximately 30% lower free D-aspartate and 25% higher DDO activity; the D-aspartate reduction was not detected in hippocampus.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"730f5170-d01b-52a3-baee-fe7dc3af0e9e","mechanism_event_label":"The measured difference was local to a brain region.","subject":{"id":"77218d67-d264-5611-beca-4d9d87253c01","slug":"human-schizophrenia-postmortem-status","display_name":"Schizophrenia diagnosis in postmortem comparisons","entity_type_key":"cellular_process"},"object":{"id":"b93f9b8e-8916-52d7-b317-b7f1bbfcca3b","slug":"human-dlpfc-free-d-aspartate","display_name":"Free D-aspartate in human dorsolateral prefrontal cortex","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"730f5170-d01b-52a3-baee-fe7dc3af0e9e","stable_key":"9a47f338-d127-5e4d-abf6-e99056833a69:d-aspartate-human-low-dasp-event","event_type":"observed_relationship","label":"The measured difference was local to a brain region.","description":"Schizophrenia DLPFC samples had approximately 30% lower free D-aspartate and 25% higher DDO activity; the D-aspartate reduction was not detected in hippocampus.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"77218d67-d264-5611-beca-4d9d87253c01","slug":"human-schizophrenia-postmortem-status","display_name":"Schizophrenia diagnosis in postmortem comparisons","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b93f9b8e-8916-52d7-b317-b7f1bbfcca3b","slug":"human-dlpfc-free-d-aspartate","display_name":"Free D-aspartate in human dorsolateral prefrontal cortex","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"b3404670-6db1-517f-b9a0-27ecfaac558b","slug":"d-aspartate","display_name":"D-Aspartate","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"17871951-099f-5a48-832e-ff9cb1c65755","slug":"ddo","display_name":"Human D-aspartate oxidase / DDO","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary full text","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human postmortem case-control study.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Not a dietary deficiency diagnosis, proof of disease cause, or a supplementation trial.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"D-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"d-aspartate","display_name":"D-Aspartate","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"The measured difference was local to a brain region.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28560262/ · DOI 10.1038/s41537-017-0015-7","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"32dcd518-f1f1-525a-951b-90dd48f07d34","evidence_kind":"source_excerpt","locator":"Lines 304-310","start_line":304,"end_line":310,"excerpt":"## d-aspartate-human-low-dasp\nThe measured difference was local to a brain region.\nSchizophrenia DLPFC samples had approximately 30% lower free D-aspartate and 25% higher DDO activity; the D-aspartate reduction was not detected in hippocampus.\nModel: Human postmortem case-control study.\nLimitations: Not a dietary deficiency diagnosis, proof of disease cause, or a supplementation trial.\nEvidence access: Primary full text\nDecreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28560262/ · DOI 10.1038/s41537-017-0015-7","model_system":"Human postmortem case-control study.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"3751103e-e256-5615-b24f-39cc76ccfb47","stable_key":"import-9a47f338-d127-5e4d-abf6-e99056833a69","title":"D-Aspartate: synthesis, clearance, neural and endocrine mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"0a86a1008edb8a69dcc79409e76e3fd5ce59b0747be8cae8f21e43f871e76248","revision_id":"a1de4b66-263d-5452-8ed8-df853afba030","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}